These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1972932)

  • 1. neu oncogene protein and epidermal growth factor receptor are independently expressed in benign and malignant breast tissues.
    Tsutsumi Y; Naber SP; DeLellis RA; Wolfe HJ; Marks PJ; McKenzie SJ; Yin S
    Hum Pathol; 1990 Jul; 21(7):750-8. PubMed ID: 1972932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies for the analysis of oncogene overexpression. Studies of the neu oncogene in breast carcinoma.
    Naber SP; Tsutsumi Y; Yin S; Zolnay SA; Mobtaker H; Marks PJ; McKenzie SJ; DeLellis RA; Wolfe HJ
    Am J Clin Pathol; 1990 Aug; 94(2):125-36. PubMed ID: 1973590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma.
    Ito K; Sasano H; Ozawa N; Sato S; Silverberg SG; Yajima A
    Int J Gynecol Pathol; 1992 Oct; 11(4):253-7. PubMed ID: 1356938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptors in breast cancer: association with early relapse and death, poor response to hormones and interactions with neu.
    Harris AL; Nicholson S; Sainsbury JR; Farndon J; Wright C
    J Steroid Biochem; 1989; 34(1-6):123-31. PubMed ID: 2576295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical studies on oncogene products (c-erbB-2, EGFR, c-myc) and estrogen receptor in benign and malignant breast lesions. With special reference to their prognostic significance in carcinoma.
    Tauchi K; Hori S; Itoh H; Osamura RY; Tokuda Y; Tajima T
    Virchows Arch A Pathol Anat Histopathol; 1989; 416(1):65-73. PubMed ID: 2573192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
    Kokai Y; Dobashi K; Weiner DB; Myers JN; Nowell PC; Greene MI
    Proc Natl Acad Sci U S A; 1988 Aug; 85(15):5389-93. PubMed ID: 2899889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of c-erbB-2 protein and epidermal growth factor receptor in normal surface epithelium, surface inclusion cysts, and common epithelial tumours of the ovary.
    Wang DP; Konishi I; Koshiyama M; Nanbu Y; Iwai T; Nonogaki H; Mori T; Fujii S
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):393-400. PubMed ID: 1360720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical demonstration of growth factors, TGF-alpha, TGF-beta, IGF-I and neu oncogene product in benign and malignant human breast tissues.
    Mizukami Y; Nonomura A; Yamada T; Kurumaya H; Hayashi M; Koyasaki N; Taniya T; Noguchi M; Nakamura S; Matsubara F
    Anticancer Res; 1990; 10(5A):1115-26. PubMed ID: 1978632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of TGF alpha, epidermal growth factor receptor, and P-glycoprotein in normal and benign diseased breast tissues.
    Scala S; Saeki T; Lynch A; Salomon D; Merino MJ; Bates SE
    Diagn Mol Pathol; 1995 Jun; 4(2):136-42. PubMed ID: 7551294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-erbB2 expression in correlation to other biological parameters of breast cancer.
    Marx D; Schauer A; Reiche C; May A; Ummenhofer L; Reles A; Rauschecker H; Sauer R; Schumacher M
    J Cancer Res Clin Oncol; 1990; 116(1):15-20. PubMed ID: 1968902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients.
    Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T
    Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of erbB-2/neu levels in tissue.
    Paik S; King CR; Simpson S; Lippman ME
    Methods Enzymol; 1991; 198():290-300. PubMed ID: 1677445
    [No Abstract]   [Full Text] [Related]  

  • 13. Type 1 protein tyrosine kinases in benign and malignant breast lesions.
    Suo Z; Emilsen E; Tveit KM; Nesland JM
    Histopathology; 1998 Dec; 33(6):514-21. PubMed ID: 9870145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study.
    Toi M; Tominaga T; Osaki A; Toge T
    Breast Cancer Res Treat; 1994 Jan; 29(1):51-8. PubMed ID: 7912567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity.
    Stern DF; Heffernan PA; Weinberg RA
    Mol Cell Biol; 1986 May; 6(5):1729-40. PubMed ID: 2878363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer.
    Wright C; Nicholson S; Angus B; Sainsbury JR; Farndon J; Cairns J; Harris AL; Horne CH
    Br J Cancer; 1992 Jan; 65(1):118-21. PubMed ID: 1346366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-erbB-2 proto-oncogene product and nuclear DNA content in benign and malignant human breast parenchyma.
    Schimmelpenning H; Eriksson ET; Falkmer UG; Azavedo E; Svane G; Auer GU
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):433-40. PubMed ID: 1350695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of c-kit in common benign and malignant breast lesions.
    Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
    Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
    Lipponen P; Eskelinen M
    Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor status in breast cancer metastases to the central nervous system. Comparison with HER-2/neu status.
    Grupka NL; Lear-Kaul KC; Kleinschmidt-DeMasters BK; Singh M
    Arch Pathol Lab Med; 2004 Sep; 128(9):974-9. PubMed ID: 15335267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.